LIA
BSX icon

Limestone Investment Advisors’s Boston Scientific BSX Stock Holding History

Limestone Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,582
Closed -$447K – 479
2025
Q3 		$447K Buy
4,582
+3,002
+190% +$311K 0.04% 295
2025
Q2 		$170K Buy
+1,580
New +$160K 0.01% 398

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Limestone Investment Advisors's BSX Position: Q4 2025 in Review

Limestone Investment Advisors sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 4,582 shares — an estimated $447K sold.

Limestone Investment Advisors first reported a position in BSX in Q2 2025 and held it in 2 quarters. The position peaked at $447K in Q3 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Limestone Investment Advisors reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Limestone Investment Advisors sold 4,582 Boston Scientific shares in Q4 2025, an estimated $447K.
  • Limestone Investment Advisors first reported a position in Boston Scientific in Q2 2025 and held it in 2 quarters.
  • Limestone Investment Advisors's Boston Scientific position peaked at $447K in Q3 2025.
  • 1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Limestone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.